Integral Health Asset Management LLC Has $60.91 Million Stock Holdings in Tenet Healthcare Corporation $THC

Integral Health Asset Management LLC lifted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 9.1% during the third quarter, HoldingsChannel reports. The firm owned 300,000 shares of the company’s stock after acquiring an additional 25,000 shares during the quarter. Tenet Healthcare comprises 4.1% of Integral Health Asset Management LLC’s holdings, making the stock its 3rd largest holding. Integral Health Asset Management LLC’s holdings in Tenet Healthcare were worth $60,912,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Sirios Capital Management L P raised its holdings in Tenet Healthcare by 100.9% during the 3rd quarter. Sirios Capital Management L P now owns 71,566 shares of the company’s stock worth $14,531,000 after buying an additional 35,947 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Tenet Healthcare by 41.6% in the third quarter. Wellington Management Group LLP now owns 93,541 shares of the company’s stock valued at $18,993,000 after buying an additional 27,479 shares during the period. NorthRock Partners LLC bought a new stake in shares of Tenet Healthcare during the third quarter worth $365,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Tenet Healthcare during the third quarter worth $149,000. Finally, Pathstone Holdings LLC lifted its position in Tenet Healthcare by 15.4% in the 3rd quarter. Pathstone Holdings LLC now owns 18,595 shares of the company’s stock valued at $3,776,000 after acquiring an additional 2,485 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on THC. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Leerink Partners upped their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research report on Friday, February 20th. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a research report on Monday, February 16th. Finally, Guggenheim raised their price target on shares of Tenet Healthcare from $271.00 to $283.00 and gave the stock a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $250.56.

Insider Activity at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. The trade was a 74.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,695 shares of company stock valued at $11,373,201 over the last three months. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Price Performance

NYSE:THC opened at $227.79 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $247.21. The stock’s 50 day moving average price is $213.46 and its two-hundred day moving average price is $203.99. The firm has a market capitalization of $19.81 billion, a price-to-earnings ratio of 14.71, a P/E/G ratio of 1.11 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same period in the previous year, the firm earned $3.44 EPS. The firm’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.